senolytic approvals
7 Years of Senolytic Approvals Push Longevity Science Far
Senolytic approvals have accelerated the transition from theory to therapy in longevity science, giving researchers concrete tools to target aging cells. The FDA’s recent clearance of two senolytic drugs validates a seven-year effort to move senescence-targeted interventions into mainstream medicine. In 2024 the FDA approved two senolytic drugs, marking